F15.24
Other stimulant dependence with stimulant-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine or other stimulant use disorder, moderate, with amphetamine or other stimulant-induced bipolar or related disorder
- Amphetamine or other stimulant use disorder, moderate, with amphetamine or other stimulant induced depressive disorder
- Amphetamine or other stimulant use disorder, severe, with amphetamine or other stimulant-induced bipolar or related disorder
- Amphetamine or other stimulant use disorder, severe, with amphetamine or other stimulant-induced depressive disorder
Medical Intelligence & Overview
ICD-10 code F15.24 refers to a condition where an individual is dependent on stimulants—such as amphetamine or other similar drugs—and experiences mood disorders caused by their use. This condition highlights the complex interplay between stimulant addiction and the development of mood-related symptoms, which can manifest as bipolar or depressive episodes triggered by the substance. Recognizing this condition is important in understanding the broader impacts of stimulant misuse on mental health and guiding appropriate treatment approaches.
Causes & Symptoms
Clinical Causes: Repeated use of stimulant drugs like amphetamine, methamphetamine, or other related substances Prolonged abuse leading to physical and psychological dependence Genetic predisposition influencing susceptibility to addiction and mood disorders Environmental factors such as stress, trauma, or social influences that contribute to substance use Co-occurring mental health conditions that increase vulnerability to substance dependence
Key Symptoms: Elevated or irritable mood, sometimes alternating with depressive episodes Episodes of intense euphoria or mood swings Depressive symptoms such as low mood, fatigue, or loss of pleasure (anhedonia) Increased energy, talkativeness, or hyperactivity during manic-like phases Sleep disturbances, including insomnia or hypersomnia Changes in appetite or weight Impulsive behavior or poor judgment Cravings for stimulants and difficulties stopping use Anxiety or agitation
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including a detailed history of stimulant use and mental health symptoms. Healthcare providers may use standardized questionnaires, clinical interviews, and laboratory tests to confirm substance dependence and distinguish mood disorder symptoms related to stimulant use. It's essential to evaluate the severity of dependence and the specific nature of the mood disturbances occurring in relation to stimulant intake.
Treatment Protocols: Treatment strategies typically encompass a combination of approaches aimed at managing both stimulant dependence and mood disturbances. These may include: - **Detoxification**: Medical supervision to safely manage withdrawal symptoms - **Psychotherapy**: Cognitive-behavioral therapy (CBT), contingency management, and counseling to address addiction behaviors and co-occurring mental health issues - **Medication**: Use of antidepressants, mood stabilizers, or other medications as appropriate to stabilize mood symptoms - **Support groups**: Engagement with peer support communities to foster recovery - **Long-term monitoring**: Ongoing mental health and substance use management to prevent relapse It is crucial for treatment plans to be individualized, considering the severity of dependence and the specific mood disorder involved.
Clinical Advice & FAQs
Billing Guidance
Is F15.24 a billable ICD-10 code?
Yes, F15.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.24?
Clinical documentation must specify the nature of Other stimulant dependence with stimulant-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference